Green light for Novavax COVID-19 vaccine in the EU
The European Commission has granted conditional marketing authorisation to Novavax for its COVID-19 vaccine: making it the first protein-based COVID-19 vaccine in the EU.
Archives for December 20, 2021
‘Reassuring’: Moderna booster increases antibodies against Omicron
A booster shot of Moderna’s COVID-19 vaccine increases neutralizing antibody levels against Omicron approximately 37-fold compared to pre-boost levels, according to data released by the company today.
AstraZeneca and Amgen’s asthma biologic approved in the US
AstraZeneca and Amgen’s Tezspire (tezepelumab-ekko) has been approved in the US for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma.
Aducanumab rejected in the EU: Biogen to ask EMA to re-examine application
Biogen will ask the European Medicines Agency (EMA) to re-examine its Alzheimer’s drug application, following the agency’s recommendation to refuse authorization of the drug in the EU.
Fujifilm Diosynth in $300m expansion of largest single-use facility in North America
The investment comes as part of a wider $850m global expansion by parent company Fujifilm Corporation of its biologics CDMO subsidiary.
Mesoblast considers plans for COVID treatment after Novartis exits deal
After disappointing results in Phase III trials, Novartis chooses to terminate agreement to develop COVID-19 treatment alongside Mesoblast.